Pharmacogenomics Dissemination of Information

An Introduction to Pharmacogenomics for Behavioral Health Nurses This program has been approved for one contact hour for nurses by the Really Important Contact Hour Approver This course is valid for two years and expires 8/31/2013

Objectives ,[object Object],[object Object],[object Object]

Background ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: The Human Genome Project Information, http://www.ornl.gov/sci/techresources/Human_Genome/project/info.shtml

Background ,[object Object],[object Object],[object Object],[object Object],[object Object],Source: The Human Genome Project Information, http://www.ornl.gov/sci/techresources/Human_Genome/project/info.shtml

The Human Genome Project ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: The Human Genome Project Information, http://www.ornl.gov/sci/techresources/Human_Genome/project/about.shtml

SNPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: The Human Genome Project Information, http://www.ornl.gov/sci/techresources/Human_Genome/faq/snps.shtml

SNPs and Pharmacogenomics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: The Human Genome Project Information, http://www.ornl.gov/sci/techresources/Human_Genome/medicine/pharma.shtml

Drugs that undergo metabolism by CYP2D6 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: Mayo Clinic Laboratories, http://www.mayomedicallaboratories.com/test-catalog/ Clinical+and+Interpretive/83180

SNPs and Pharmacogenomics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: National Human Genome Research Institute, http://www.genome.gov/27530645

Pharmacogenomics in Prescribing ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: The Human Genome Project Information, http://www.ornl.gov/sci/techresources/Human_Genome/medicine/pharma.shtml

Pharmacogenomics and Venlafaxine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pharmacogenomics and Venlafaxine ,[object Object],[object Object],[object Object],[object Object],[object Object]

Pharmacogenomics and Venlafaxine ,[object Object],[object Object],[object Object],[object Object]

Pharmacogenomics and Venlafaxine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

What conclusions can we draw? ,[object Object],[object Object],[object Object]

Implications for clinicians ,[object Object],[object Object],[object Object],[object Object],[object Object]

References – Understanding Pharmacogenomics ,[object Object],[object Object],[object Object]

References – Understanding Pharmacogenomics ,[object Object],[object Object],[object Object],[object Object]

References – Venlafaxine Studies ,[object Object],[object Object],[object Object]

References – Venlafaxine Studies ,[object Object],[object Object]

Pharmacogenomics Dissemination of Information

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

Similaire à Pharmacogenomics Dissemination of Information

Similaire à Pharmacogenomics Dissemination of Information (20)

Dernier

Dernier (20)

Pharmacogenomics Dissemination of Information

Notes de l'éditeur